Ampath Chats

Drugs of Abuse Screening (DOAS)

Ampath Chats
Drugs of Abuse Screening (DOAS)
Read Document

PATHCHAT Edition No. 41
Please contact your local Ampath pathologist for more information.

Authors: Dr. N. Lutchman and Dr. M. du Plessis

Introduction

🔹 Why is DOAS Important?

  • Used in workplace drug testing, professional sports, emergency departments, and trauma units.
  • Helps guide medical management in patients with altered mental states or suspected drug overdose.

Ampath’s Standard Urine Screening Panel Includes:

  • Amphetamines.
  • Benzodiazepines.
  • Cannabis.
  • Cocaine.
  • Mandrax (Methaqualone).
  • Methadone.
  • Opiates.
  • Confirmatory tests for Ecstasy (MDMA), Methamphetamine (Tik), and Methcathinone (CAT).

📌 Barbiturates are tested as part of the urine toxic screen with benzodiazepines and can also be requested separately.

DOAS Screening & Confirmatory Testing

Types of DOAS Testing Available at Ampath:

  • Qualitative Screening (Dipstick Testing – Immunochromatography).
  • Quantitative Immunoassay Testing (Standard Screening).
  • Confirmatory Testing Using Tandem Mass Spectrometry:
    • Gas Chromatography-Mass Spectrometry (GC-MS/MS).
    • Liquid Chromatography-Mass Spectrometry (LC-MS/MS).

Key Considerations:

  • Immunoassays have high sensitivity but lower specificity for certain drug classes (e.g., opiates, amphetamines).
  • A positive screening result is considered presumptive and must be confirmed by mass spectrometry.

📌 Confirmatory testing is essential to differentiate between similar compounds and rule out false positives.

Specimen Collection & Integrity Checks

Preferred Sample:

  • Urine is the preferred specimen due to its ease of collection and longer drug detection window.

Specimen Integrity Testing:

  • Urine pH should be between 4.5 and 8.0.
  • pH <3 or >11 suggests adulteration.
  • Creatinine levels <20 mg/dL may indicate dilution.

📌 Tampering methods include adulterants, substitution, and dilution; hence, supervised collection and integrity checks are essential.

Cut-Off Levels & Drug Detection Windows

🔹 Ampath follows the Substance Abuse and Mental Health Administration (SAMHSA) cut-off levels for adult drug screening.

  • Values below the cut-off level are reported as negative.
  • Detection windows vary by drug type and usage frequency.

📌 There are four major drug groups tested in DOAS: Psychostimulants, Hallucinogens, Anaesthetics, and Analgesics.

1. Psychostimulants

Amphetamines (Speed, Methamphetamine – Tik)

Key Features:

  • Cleared rapidly from blood; urine is the preferred specimen.
  • Detected in urine for up to 4 days post-use.
  • Cross-reactivity with pseudoephedrine, ephedrine, phenylephrine, and phentermine.

📌 Screening detects MDMA (Ecstasy) and methamphetamine (Tik) to varying degrees.

Cut-Off Level: 1,000 ng/mL

Methamphetamine (Tik, Crystal Meth, Ice)

Key Features:

  • Metabolized to amphetamine.
  • Methamphetamine-positive urine usually contains amphetamine as well.
  • Cross-reactivity with MDMA (Ecstasy).

📌 LC-MS/MS can distinguish methamphetamine from MDMA.

Cut-Off Level: 1,000 ng/mL

Cocaine (Coke, Crack)

Key Features:

  • Metabolized to benzoylecgonine (detected in urine).
  • Highly specific immunoassay – false positives are uncommon.
  • Detected for up to 2 days in occasional users, up to 7 days in chronic users.

Cut-Off Level: 300 ng/mL

2. Hallucinogens

Cannabis (Marijuana, Dagga, Grass, Pot)

Key Features:

  • Primary psychoactive component: Δ9-Tetrahydrocannabinol (THC).
  • Highly lipophilic, leading to prolonged excretion.
  • Detected for up to 7 days in occasional users, up to 30 days in chronic users.
  • False positives with Efavirenz (HIV drug) and some proton pump inhibitors (PPIs).

📌 Synthetic cannabinoids are NOT detected by standard urine assays.

Cut-Off Level: 50 ng/mL

Lysergic Acid Diethylamide (LSD – Acid)

Key Features:

  • Minimal amounts excreted in urine.
  • Short detection window (~4 hours).
  • Confirmatory testing available (LC-MS/MS only).

Phencyclidine (PCP – Angel Dust)

Key Features:

  • Low specificity of immunoassay results in false positives.
  • Detected for 4–7 days post-use.
  • False positives with diphenhydramine (Benadryl) and dextromethorphan.

Cut-Off Level: 25 ng/mL

3. Anaesthetics

Barbiturates (Downers, Barbs)

Key Features:

  • Short- or long-acting (detectable for 1–14 days).
  • Often abused to induce sleep after stimulant use.

Cut-Off Level: 200 ng/mL

Benzodiazepines (Tranquilizers, Sleeping Pills)

Key Features:

  • Commonly prescribed – difficult to distinguish abuse from therapeutic use.
  • Detected for 1–7 days; diazepam metabolites may persist for weeks.
  • Roche immunoassay cross-reacts with Alprazolam (Xanax), Clonazepam, Midazolam, and Flunitrazepam (Rohypnol).
  • Sleeping aids (Zolpidem, Zopiclone) are NOT detected by this assay.

Cut-Off Level: 2,000 ng/mL

4. Analgesics

Opioids (Morphine, Heroin, Codeine, Synthetic Opioids)

Key Features:

  • Class includes natural (morphine, codeine), semi-synthetic (oxycodone, hydromorphone), and synthetic opioids (fentanyl, methadone).
  • Immunoassays detect morphine, heroin, and codeine.
  • Synthetic opioids (fentanyl, oxycodone) require specific assays.
  • Poppy seeds do NOT cause false positives when using SAMHSA cut-offs.

Cut-Off Level: 2,000 ng/mL

Mandrax (Methaqualone – White Pipe, Buttons)

Key Features:

  • Commonly abused in South Africa.
  • Often mixed with cannabis or smoked alone.

Cut-Off Level: 300 ng/mL

Conclusion

Urine is the preferred sample for DOAS due to longer drug detection times.
Screening results must be confirmed by mass spectrometry for legal or forensic use.
Specimen integrity tests (pH, creatinine) ensure sample validity.
Specific immunoassays are required for synthetic opioids and designer drugs.

📌 DOAS is an essential tool in medical management, workplace drug testing, and forensic investigations.